Total Payments
$5,085
2024 Payments
$517.91
Companies
22
Transactions
171
Medicare Patients
5,599
Medicare Billing
$394,732
Payment Breakdown by Category
Food & Beverage$3,648 (71.7%)
Consulting$1,180 (23.2%)
Education$256.56 (5.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,648 | 164 | 71.7% |
| Consulting Fee | $1,180 | 1 | 23.2% |
| Education | $256.56 | 6 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $1,287 | 7 | $0 (2024) |
| ABBVIE INC. | $1,203 | 64 | $0 (2024) |
| Janssen Biotech, Inc. | $336.99 | 12 | $0 (2024) |
| Amgen Inc. | $336.51 | 18 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $321.61 | 18 | $0 (2024) |
| LEO Pharma Inc. | $229.92 | 4 | $0 (2023) |
| GENZYME CORPORATION | $178.22 | 5 | $0 (2023) |
| Allergan Inc. | $147.18 | 2 | $0 (2018) |
| Lilly USA, LLC | $131.78 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $121.73 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $517.91 | 29 | ABBVIE INC. ($159.07) |
| 2023 | $2,359 | 59 | UCB, Inc. ($1,215) |
| 2022 | $858.92 | 46 | ABBVIE INC. ($452.72) |
| 2021 | $379.59 | 27 | AbbVie Inc. ($182.76) |
| 2019 | $532.98 | 5 | AbbVie, Inc. ($243.38) |
| 2018 | $245.44 | 3 | Allergan Inc. ($147.18) |
| 2017 | $190.68 | 2 | LEO Pharma Inc. ($125.73) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $30.83 | General |
| Category: Immunology | ||||||
| 09/26/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: DERMATOLOGY | ||||||
| 09/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Immunology | ||||||
| 09/10/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: DERMATOLOGY | ||||||
| 08/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Dermatology | ||||||
| 05/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: IMMUNOLOGY | ||||||
| 04/30/2024 | ABBVIE INC. | HUMIRA (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: IMMUNOLOGY | ||||||
| 04/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.96 | General |
| Category: Immunology | ||||||
| 04/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: IMMUNOLOGY | ||||||
| 04/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Dermatology | ||||||
| 04/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Immunology | ||||||
| 03/27/2024 | ABBVIE INC. | HUMIRA (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: IMMUNOLOGY | ||||||
| 03/27/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 03/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: IMMUNOLOGY | ||||||
| 03/19/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $13.93 | General |
| Category: Dermatology | ||||||
| 03/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.07 | General |
| Category: Immunology | ||||||
| 02/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: IMMUNOLOGY | ||||||
| 02/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Immunology | ||||||
| 02/15/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Immunology | ||||||
| 02/13/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Inflammation | ||||||
| 01/25/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Monoclonal Antibody | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,135 | 3,378 | $446,149 | $157,354 |
| 2022 | 20 | 1,889 | 2,878 | $373,239 | $134,355 |
| 2021 | 14 | 1,179 | 1,735 | $209,121 | $82,768 |
| 2020 | 10 | 396 | 613 | $94,990 | $20,255 |
Total Patients
5,599
Total Services
8,604
Medicare Billing
$394,732
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 441 | 513 | $78,843 | $31,802 | 40.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 230 | 293 | $63,651 | $25,372 | 39.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 246 | 283 | $60,279 | $21,988 | 36.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 235 | 252 | $51,660 | $15,539 | 30.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 266 | 301 | $44,247 | $11,017 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 84 | 84 | $26,124 | $9,890 | 37.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 124 | 124 | $25,386 | $9,003 | 35.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 42 | 50 | $15,900 | $6,083 | 38.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 211 | 1,139 | $19,363 | $5,501 | 28.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 17 | 18 | $10,386 | $4,341 | 41.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 61 | 108 | $11,988 | $4,308 | 35.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 36 | 39 | $10,062 | $3,470 | 34.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 23 | $7,728 | $2,513 | 32.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 49 | 52 | $5,069 | $2,099 | 41.4% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 18 | 18 | $4,500 | $1,595 | 35.5% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 14 | $6,608 | $1,396 | 21.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 17 | 17 | $2,448 | $876.15 | 35.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 12 | 17 | $1,791 | $534.21 | 29.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 33 | $115.50 | $27.30 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 370 | 429 | $60,813 | $26,007 | 42.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 185 | 229 | $46,166 | $19,256 | 41.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 226 | 251 | $50,953 | $18,501 | 36.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 163 | 163 | $31,785 | $12,351 | 38.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 180 | 185 | $37,925 | $10,655 | 28.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 208 | 222 | $31,080 | $7,966 | 25.6% |
About Dr. Michael Milliken, MD
Dr. Michael Milliken, MD is a Dermatology healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1629275037.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Milliken, MD has received a total of $5,085 in payments from pharmaceutical and medical device companies, with $517.91 received in 2024. These payments were reported across 171 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,648).
As a Medicare-enrolled provider, Milliken has provided services to 5,599 Medicare beneficiaries, totaling 8,604 services with total Medicare billing of $394,732. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Internal Medicine, Dermatology
- Location Fort Worth, TX
- Active Since 06/29/2007
- Last Updated 07/29/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1629275037
Products in Payments
- SKYRIZI (Biological) $512.79
- Otezla (Drug) $336.51
- RINVOQ (Biological) $294.60
- Sotyktu (Drug) $288.71
- Humira (Biological) $243.38
- DUPIXENT (Biological) $197.39
- HUMIRA (Biological) $143.74
- TALTZ (Drug) $131.78
- ENSTILAR (Drug) $125.73
- ADBRY (Biological) $104.19
- TREMFYA (Drug) $102.93
- COSENTYX (Drug) $102.84
- Tremfya (Drug) $99.99
- DUPIXENT (Drug) $99.03
- WATCHMAN (Device) $90.58
- EUCRISA (Drug) $88.94
- OPZELURA (Drug) $87.23
- REMICADE (Biological) $69.12
- STELARA (Biological) $64.95
- Cimzia (Drug) $56.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Fort Worth
Dr. Patrick Keehan, D.o, D.O
Dermatology — Payments: $761,024
Dermatology $761,024
Dr. Ronald Plott, M.d, M.D
Dermatology — Payments: $467,637
Dermatology $467,637
William Cothern, Do, DO
Dermatology — Payments: $41,403
Dermatology $41,403
Stephen Weis, Do, DO
Dermatology — Payments: $32,162
Dermatology $32,162
Kathryn Durham, Md, MD
Dermatology — Payments: $28,437
Dermatology $28,437
Mrs. Betty Rajan, M.d, M.D
Dermatology — Payments: $25,857
Dermatology $25,857